NCT01685931View on ClinicalTrials.gov

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

PHASE4CompletedINTERVENTIONAL
Enrollment

617

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone Palmitate

One intramuscular injection of paliperidone palmitate flexible dose will be administered on Day 1, Day 8, and monthly thereafter.

Trial Locations (17)

Unknown

Baoding

Beijing

Chengdu

Chongqing

Fuzhou

Guangzhou

Hangzhou

Jinan

Nanjing

Qingdao

Shantou

Shenzhen

Shijiazhuang

Suzhou

Taiyuan

Tianjin

Wuhan

All Listed Sponsors
lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT01685931 - A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics | Biotech Hunter | Biotech Hunter